title: Analysis of mutations in the gyrA and gyrB genes and their association with the resistance of Mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin.
abstract: The purpose of the present study was to analyse mutations in the gyrA and gyrB genes of Mycobacterium tuberculosis and define the possible correlation between these mutations and resistance to levofloxacin (LVX), moxifloxacin (MFX) and gatifloxacin (GAT), based on their MICs. One hundred and forty-two M. tuberculosis clinical isolates were collected from pulmonary tuberculosis patients in the Moscow region. All M. tuberculosis strains were tested for drug susceptibility to rifampicin and isoniazid using the BACTEC MGIT 960 System and to ofloxacin (OFX) using the absolute concentration method on solid Lowenstein-Jensen slants. All in all, 68 strains were selected at random (38 strains were resistant and 30 were susceptible to OFX) for further analysis using the TB-BIOCHIP-2 test system and DNA sequence analysis. The MICs of LVX, MFX and GAT for selected strains were determined using the BACTEC MGIT 960 System. Mutations in the gyrA gene were observed in 36 out of 38 (94.7 %) OFX-resistant M. tuberculosis strains. Asn538Asp and Asp500His substitutions in the gyrB gene only were found in two (5.3 %) strains. Twenty-nine out of 30 OFX-sensitive M. tuberculosis strains had no mutations in either gene. One (3.3 %) OFX-sensitive M. tuberculosis strain carried an Arg485His substitution in gyrB. The results of our investigation showed that there is no clear correlation between the type of mutation in the genes gyrA and gyrB, and the MIC levels of LVX, MFX and GAT for resistant strains. Mutations in gyrA and Asn538Asp, and Asp500His substitutions in gyrB were associated with cross-resistance of M. tuberculosis to fluoroquinolones. The substitution Arg485His in gyrB does not confer resistance to LVX, MFX and GAT in M. tuberculosis.
authors.affiliation: Moscow Scientific and Clinical Antituberculosis Center, Moscow Government Health Department, Stromynka 10, Moscow 107014, Russia.
authors.forename: Elena Yu
authors.initials: EY
authors.lastname: Nosova
authors.affiliation: Moscow Scientific and Clinical Antituberculosis Center, Moscow Government Health Department, Stromynka 10, Moscow 107014, Russia.
authors.forename: Anastasia A
authors.initials: AA
authors.lastname: Bukatina
authors.affiliation: Moscow Scientific and Clinical Antituberculosis Center, Moscow Government Health Department, Stromynka 10, Moscow 107014, Russia.
authors.forename: Yulia D
authors.initials: YD
authors.lastname: Isaeva
authors.affiliation: Moscow Scientific and Clinical Antituberculosis Center, Moscow Government Health Department, Stromynka 10, Moscow 107014, Russia.
authors.forename: Marina V
authors.initials: MV
authors.lastname: Makarova
authors.affiliation: Moscow Scientific and Clinical Antituberculosis Center, Moscow Government Health Department, Stromynka 10, Moscow 107014, Russia.
authors.forename: Ksenia Yu
authors.initials: KY
authors.lastname: Galkina
authors.affiliation: Moscow Scientific and Clinical Antituberculosis Center, Moscow Government Health Department, Stromynka 10, Moscow 107014, Russia.
authors.forename: Arkadyi M
authors.initials: AM
authors.lastname: Moroz
mesh_terms: D000995:Antitubercular Agents / Q000494:pharmacology*; D001372:Aza Compounds / Q000494:pharmacology; D027081:DNA Gyrase / Q000235:genetics* / Q000378:metabolism; D024881:Drug Resistance, Bacterial / Q000235:genetics; D024841:Fluoroquinolones / Q000494:pharmacology; D000077734:Gatifloxacin; D015964:Gene Expression Regulation, Bacterial; D006801:Humans; D064704:Levofloxacin; D008826:Microbial Sensitivity Tests; D000077266:Moxifloxacin; D009154:Mutation; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000235:genetics*; D015242:Ofloxacin / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D012426:Russia / Q000453:epidemiology; D014397:Tuberculosis, Pulmonary / Q000453:epidemiology / Q000382:microbiology
chemical_list: D000995:Antitubercular Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D064704:Levofloxacin; D015242:Ofloxacin; D027081:DNA Gyrase; D000077734:Gatifloxacin; D000077266:Moxifloxacin